Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression. This is a ...
MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector. The rebrand comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback